Scott Eliasof

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Finance

Profil

Scott Eliasof served as Director-Chemical Biology Platform at Harvard University, Massachusetts Institute of Technology, and The Broad Institute, Inc. He also worked as Principal at Millennium Pharmaceuticals, Inc. and Neurocrine Biosciences, Inc. Later, he served as Chief Scientific Officer & Senior Vice President at Cerulean Pharma, Inc. and Daré Bioscience,.
Inc. Eliasof completed his undergraduate degree at Massachusetts Institute of Technology and earned his doctorate from the University of California, Berkeley.

Ehemalige bekannte Positionen von Scott Eliasof

Unternehmen	Position	Ende
Cerulean Pharma, Inc. Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals	Technik-/Wissenschafts-/F&E-Leiter	30.06.2017
DARÉ BIOSCIENCE, INC.	Technik-/Wissenschafts-/F&E-Leiter	-
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases	Corporate Officer/Principal	-
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Corporate Officer/Principal	-
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Scott Eliasof im Detail an

Ausbildung von Scott Eliasof

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Scott Eliasof im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	8
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment	Health Technology
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders	Health Technology
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cerulean Pharma, Inc. Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals	Health Technology
The Broad Institute, Inc. The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases	Health Technology
Daré Bioscience, Inc. Daré Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products	Health Technology